These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 36352305)

  • 21. Pharmacological Pain Treatment in 2012 and 2017 Among Older People with Major Neurocognitive Disorder.
    Gustafsson M; Lövheim H; Sjölander M
    Drugs Aging; 2021 Nov; 38(11):1017-1023. PubMed ID: 34664213
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prescription of QT-prolonging drugs in a cohort of about 5 million outpatients.
    Curtis LH; Østbye T; Sendersky V; Hutchison S; Allen LaPointe NM; Al-Khatib SM; Usdin Yasuda S; Dans PE; Wright A; Califf RM; Woosley RL; Schulman KA
    Am J Med; 2003 Feb; 114(2):135-41. PubMed ID: 12586234
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Leading 20 drug-drug interactions, polypharmacy, and analysis of the nature of risk factors due to QT interval prolonging drug use and potentially inappropriate psychotropic use in elderly psychiatry outpatients.
    Das B; Ramasubbu SK; Agnihotri A; Kumar B; Rawat VS
    Ther Adv Cardiovasc Dis; 2021; 15():17539447211058892. PubMed ID: 34841978
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Multiple categories of non-cardiac QT-prolonging drugs are associated with increased risk of out-of-hospital cardiac arrest: real-world data from a population-based study.
    Eroglu TE; Blom MT; Souverein PC; de Boer A; Tan HL
    Europace; 2022 Apr; 24(4):630-638. PubMed ID: 34661653
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of West Virginia medicaid claims data for the prevalence of medical conditions and use of drugs likely to cause QT prolongation in patients with schizophrenia.
    Kalsekar ID; Makela EH; Moeller KE
    Curr Ther Res Clin Exp; 2003 Sep; 64(8):538-50. PubMed ID: 24944403
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Potentially Inappropriate Medications Pre- and Post-Diagnosis of Major Neurocognitive Disorders Among Older People in Sweden: A Register-Based, 6-Year Longitudinal Study.
    Sönnerstam E; Gustafsson M; Lövheim H; Sjölander M
    Drugs Aging; 2022 Jul; 39(7):573-585. PubMed ID: 35655061
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High prevalence of risk factors in elderly patients using drugs associated with acquired torsades de pointes chronically in Colombia.
    Moreno-Gutiérrez PA; Gaviria-Mendoza A; Cañón MM; Machado-Alba JE
    Br J Clin Pharmacol; 2016 Aug; 82(2):504-11. PubMed ID: 27060989
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Investigating the Additive Interaction of QT-Prolonging Drugs in Older People Using Claims Data.
    Meid AD; von Medem A; Heider D; Adler JB; Günster C; Seidling HM; Quinzler R; König HH; Haefeli WE
    Drug Saf; 2017 Feb; 40(2):133-144. PubMed ID: 27896662
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevalence and determinants of QT interval prolongation in medical inpatients.
    Pasquier M; Pantet O; Hugli O; Pruvot E; Buclin T; Waeber G; Aujesky D
    Intern Med J; 2012 Aug; 42(8):933-40. PubMed ID: 21299787
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Methadone maintenance, QTc and torsade de pointes: who needs an electrocardiogram and what is the prevalence of QTc prolongation?
    Mayet S; Gossop M; Lintzeris N; Markides V; Strang J
    Drug Alcohol Rev; 2011 Jul; 30(4):388-96. PubMed ID: 21355918
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Frequency of high-risk use of QT-prolonging medications.
    Allen LaPointe NM; Curtis LH; Chan KA; Kramer JM; Lafata JE; Gurwitz JH; Raebel MA; Platt R
    Pharmacoepidemiol Drug Saf; 2006 Jun; 15(6):361-8. PubMed ID: 16178046
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of potentially inappropriate medications among old people with major neurocognitive disorder in 2012 and 2017.
    Rangfast I; Sönnerstam E; Gustafsson M
    BMC Geriatr; 2022 Jun; 22(1):544. PubMed ID: 35773643
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common Genetic Variant Risk Score Is Associated With Drug-Induced QT Prolongation and Torsade de Pointes Risk: A Pilot Study.
    Strauss DG; Vicente J; Johannesen L; Blinova K; Mason JW; Weeke P; Behr ER; Roden DM; Woosley R; Kosova G; Rosenberg MA; Newton-Cheh C
    Circulation; 2017 Apr; 135(14):1300-1310. PubMed ID: 28213480
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Dear Doctor Letters regarding citalopram and escitalopram: guidelines vs real-world data.
    de Bardeci M; Greil W; Stassen H; Willms J; Köberle U; Bridler R; Hasler G; Kasper S; Rüther E; Bleich S; Toto S; Grohmann R; Seifert J
    Eur Arch Psychiatry Clin Neurosci; 2023 Feb; 273(1):65-74. PubMed ID: 35217913
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Combinations of QTc-prolonging drugs: towards disentangling pharmacokinetic and pharmacodynamic effects in their potentially additive nature.
    Meid AD; Bighelli I; Mächler S; Mikus G; Carrà G; Castellazzi M; Lucii C; Martinotti G; Nosè M; Ostuzzi G; Barbui C; Haefeli WE
    Ther Adv Psychopharmacol; 2017 Dec; 7(12):251-264. PubMed ID: 29201344
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Identification of Risk of QT Prolongation by Pharmacists When Conducting Medication Reviews in Residential Aged Care Settings: A Missed Opportunity?
    Christensen L; Turner JR; Peterson GM; Naunton M; Thomas J; Yee KC; Kosari S
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31689908
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-Associated QTc Prolongation in Geriatric Hospitalized Patients: A Cross-Sectional Study in Internal Medicine.
    Rossi M; Marzi F; Natale M; Porceddu A; Tuccori M; Lazzerini PE; Laghi-Pasini F; Capecchi PL
    Drugs Real World Outcomes; 2021 Sep; 8(3):325-335. PubMed ID: 33834380
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Pharmacoepidemiology of QT-interval prolonging drug administration in critically ill patients.
    Freeman BD; Dixon DJ; Coopersmith CM; Zehnbauer BA; Buchman TG
    Pharmacoepidemiol Drug Saf; 2008 Oct; 17(10):971-81. PubMed ID: 18693297
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Risk management of QT-prolonging drugs by community pharmacists using a mobile electrocardiograph].
    Shinozaki K
    Yakugaku Zasshi; 2010 Nov; 130(11):1597-601. PubMed ID: 21048421
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of QTc interval prolongation and its associated risk factors among psychiatric patients: a prospective observational study.
    Ali Z; Ismail M; Nazar Z; Khan F; Khan Q; Noor S
    BMC Psychiatry; 2020 Jun; 20(1):277. PubMed ID: 32493330
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.